Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,549 | Dovepress* | 9,977+ | 1,315 | 11,292 | |
| PubMed Central* | 1,572 | 428 | 2,000 | ||
| Totals | 11,549 | 1,743 | 13,292 | ||
| *Since 30 August 2018 | |||||
View citations on PubMed Central and Google Scholar